http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101913014-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028 |
| filingDate | 2016-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101913014-B1 |
| titleOfInvention | A pharmaceutical composition for preventing or treating liver disease comprising 6''-O-Galloylsalidroside |
| abstract | The present invention relates to a pharmaceutical composition for preventing or treating liver disease comprising 6 " -O-galloyl salicylide, wherein the composition of the present invention has no effect on feed intake, body weight, or organ weight, The present invention also relates to a pharmaceutical composition for preventing and treating liver diseases such as fatty liver, liver inflammation, liver fibrosis and liver cirrhosis, which exhibits an effect of inhibiting the accumulation of triglyceride and neutral fat in blood due to alcohol, , Hepatic fibrosis, and liver function disorders such as liver cirrhosis. |
| priorityDate | 2016-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 604.